Papaver somniferum L. mediated novel bioinspired lead oxide (PbO) and iron oxide (Fe2O3) nanoparticles: In-vitro biological applications, biocompatibility and their potential towards HepG2 cell line

Mater Sci Eng C Mater Biol Appl. 2019 Oct:103:109740. doi: 10.1016/j.msec.2019.109740. Epub 2019 May 11.

Abstract

To overcome the disadvantages of chemical and physical methods, phyto-fabricated nanoparticles attained great attention due to their multifarious applications. Here we successfully demonstrated Papaver somniferum L. mediated green synthesis of lead oxide (PbO) and iron oxide (Fe2O3) nanoparticles. Characterization of nanoparticles involved techniques including X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR) and energy dispersive X-ray (EDX) associated with scanning electron microscopy (SEM). XRD analysis confirmed the phase identification and crystalline nature. FTIR analysis confirmed the capping of nanoparticles by plants' phytochemicals. SEM revealed morphological features of PbO and Fe2O3 with size of nanoparticles being 23 ± 11 nm and 38 ± 13 nm, respectively. The elemental composition of the nanoparticles was confirmed by EDX. Both bacterial and fungal isolates showed susceptibility towards PbO and Fe2O3 NPs. Both the NPs also showed considerable total antioxidant potential, free radical scavenging potential and reducing power. Insignificant level of α-amylase for both NPs was observed. Fe2O3 NPs showed superior biocompatibility with human RBCs as compared to PbO whereas PbO showed more potent anti-cancer activity as compared to Fe2O3 NPs. Overall our study concluded that both NPs played vital role in multiple biological assays however, extensive research focused on cytotoxic evaluation of NPs in-vivo is required.

Keywords: Anticancer; Biosynthesized; Iron oxide NPs; Lead oxide NPs; Papaver somniferum L..

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Antifungal Agents / chemistry
  • Antifungal Agents / pharmacology
  • Antioxidants / chemistry
  • Antioxidants / pharmacology
  • Drug Evaluation, Preclinical
  • Drug Stability
  • Erythrocytes / drug effects
  • Ferric Compounds / chemistry*
  • Hemolytic Agents / chemistry
  • Hemolytic Agents / pharmacology
  • Hep G2 Cells
  • Humans
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology
  • Lead / chemistry*
  • Metal Nanoparticles / chemistry*
  • Metal Nanoparticles / therapeutic use
  • Oxides / chemistry*
  • Papaver / chemistry
  • Papaver / metabolism*
  • Spectroscopy, Fourier Transform Infrared
  • X-Ray Diffraction
  • alpha-Amylases / antagonists & inhibitors
  • alpha-Amylases / metabolism

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Antioxidants
  • Ferric Compounds
  • Hemolytic Agents
  • Hypoglycemic Agents
  • Oxides
  • ferric oxide
  • Lead
  • lead oxide
  • alpha-Amylases